HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by EISEN, A. Articles by CAMPBELL, I. Search for Related Content PubMed PubMed Citation Articles by EISEN, A. Articles by CAMPBELL, I.

Reduced neuromuscular transmission safety factor in multiple sclerosis

Department of Neurology and Neurosurgery, and the Department of Anaesthesia, McGill University, Montreal, Quebec, Canada.

Hegional intravascular injections of d-tubocurarine (0.3 mg) were administered in the hands of 23 normal subjects and 19 patients with multiple sclerosis. The degree of neuromuscular block and rate of recovery were determined by measuring the amplitude of the first dorsal interosseus muscle action potential which was evoked periodically by trains of five stimuli (3 Hz each) to the ulnar nerve. In normal subjects, the first response to the train returned to its preinjection level after 20.0 ±8.5 minutes and the fifth response after 27.6 ± 7.8 minutes. Multiple sclerosis patients showed a significantly delayed recovery of the first response (58 percent of patients) and of the fifth response (42 percent), suggesting a latent defect of neuromuscular transmission.

Dr. Eisen's address is the Montreal Neurological Hospital, 3801 University Street, Montreal, Quebec, H3A 284, Canada.

This work was supported in part by grants from the Multiple Sclerosis Society of Canada and the Muscular Dystrophy Association of Canada.

Accepted for publication April 14, 1977.